E2F/DP prevents cell cycle progression in endocycling fatbody cells by suppressing dATM expression

To understand the consequences of the complete elimination of E2F regulation we profiled the proteome of Drosophila dDP mutants that lack functional E2F/DP complexes. The results uncovered changes in the larval fatbody, a differentiated tissue that grows via endocycles. We report an unexpected mecha...

Full description

Saved in:
Bibliographic Details
Published inDevelopmental cell Vol. 43; no. 6; pp. 689 - 703.e5
Main Authors Guarner, Ana, Morris, Robert, Korenjak, Michael, Boukhali, Myriam, Zappia, Maria Paula, Van Rechem, Capucine, Whetstine, Johnathan R., Ramaswamy, Sridhar, Zou, Lee, Frolov, Maxim V., Haas, Wilhelm, Dyson, Nicholas J.
Format Journal Article
LanguageEnglish
Published 07.12.2017
Online AccessGet full text

Cover

Loading…
More Information
Summary:To understand the consequences of the complete elimination of E2F regulation we profiled the proteome of Drosophila dDP mutants that lack functional E2F/DP complexes. The results uncovered changes in the larval fatbody, a differentiated tissue that grows via endocycles. We report an unexpected mechanism of E2F/DP action that promotes quiescence in this tissue. In the fatbody, dE2F/dDP limits cell cycle progression by suppressing DNA damage responses. Loss of dDP upregulates dATM, allowing cells to sense and repair DNA damage, and increasing replication of loci that are normally under-replicated in wild-type tissues. Genetic experiments show that ectopic dATM is sufficient to promote DNA synthesis in wild-type fatbody cells. Strikingly, reducing dATM levels in dDP-deficient fatbodies restores cell cycle control, improves tissue morphology and extends animal development. These results show that, in some cellular contexts, dE2F/dDP-dependent suppression of DNA damage signaling is key to cell cycle control and needed for normal development.
Bibliography:Present address: Stanford Medicine Department of Pathology. 269 Campus Drive, CCSR-3245C. Stanford, California 94305-5176, USA.
Present address: Molecular Mechanisms and Biomarkers Group, International Agency for Research on Cancer, 150 Cours Albert Thomas, 69008 Lyon, France.
ISSN:1534-5807
1878-1551
DOI:10.1016/j.devcel.2017.11.008